Skip to main content
Clinical Trials/DRKS00012532
DRKS00012532
Completed
Not Applicable

Association of a comprehensive geriatric assessment and toxicity, overall survival and quality of life

Kliniken Essen-Mitte0 sites208 target enrollmentOctober 13, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Geriatric tumour patients receiving chemotherapy
Sponsor
Kliniken Essen-Mitte
Enrollment
208
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2017
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Kliniken Essen-Mitte

Eligibility Criteria

Inclusion Criteria

  • Patient with histologically confirmed carcinoma or histologically confirmed aggressive B\-NHL
  • \-First diagnosis of cancer
  • \-Age 65 years and above
  • \-Estimated life expectancy of at least 3 months
  • \-Informed consent
  • \-Judged fit or vulnerable by assessment of the geriatric\-oncologic conference
  • \-Judged Unfit by assessment of the geriatric\-oncologic conference

Exclusion Criteria

  • \-Patients with leukemia, indolent lymphoma
  • \-Previous chemotherapy
  • \-Unwillingness of the patient to undergo a geriatric assessment
  • \-Imminent dialysis
  • \-Brain metastasis
  • \-Acute coronary syndrome within the last 3 months
  • \-Unwillingness to participate in regular follow\-up visits

Outcomes

Primary Outcomes

Not specified

Similar Trials